Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer

Thumbnail Image
Krishnan, Preethi
Ghosh, Sunita
Graham, Kathryn
Mackey, John R.
Kovalchuk, Olga
Damaraju, Sambasivarao
Journal Title
Journal ISSN
Volume Title
Impact Journals
Piwi-interacting RNAs (piRNAs), whose role in germline maintenance has been established, are now also being classified as post-transcriptional regulators of gene expression in somatic cells. PIWI proteins, central to piRNA biogenesis, have been identified as genetic and epigenetic regulators of gene expression. piRNAs/PIWIs have emerged as potential biomarkers for cancer but their relevance to breast cancer has not been comprehensively studied. piRNAs and mRNAs were profiled from normal and breast tumor tissues using next generation sequencing and Agilent platforms, respectively. Gene targets for differentially expressed piRNAs were identified from mRNA expression dataset. piRNAs and PIWI genes were independently assessed for their prognostic significance (outcomes: Overall Survival, OS and Recurrence Free Survival, RFS). We discovered eight piRNAs as novel independent prognostic markers and their association with OS was confirmed in an external dataset (The Cancer Genome Atlas). Further, PIWIL3 and PIWIL4 genes showed prognostic relevance. 306 gene targets exhibited reciprocal relationship with piRNA expression. Cancer cell pathways such as apoptosis and cell signaling were the key Gene Ontology terms associated with the regulated gene targets. Overall, we have captured the entire cascade of events in a dysregulated piRNA pathway and have identified novel markers for breast cancer prognostication.
Sherpa Romeo blue journal. Open access article. Creative Commons Attribution 3.0 License (CC BY 3.0) applies
piRNA , PIWI , Breast cancer , Prognostic marker , TCGA , Piwi-interacting
Krishnan, P., Ghosh, S., Graham, K., Mackey, J R., Kovalchuk, O., & Damaraju, S. (2016). Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer. Oncotarget, 7(25), 37944-37956. https://doi.org/10.18632/oncotarget.9272